×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TRVN – trevena, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TRVN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/19
03:02 am
trvn
Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/14
02:37 pm
trvn
Trevena, Inc. (NASDAQ: TRVN) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Neutral
Report
Trevena, Inc. (NASDAQ: TRVN) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
11/11
02:05 am
trvn
Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/11
02:05 am
trvn
Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/7
07:01 am
trvn
Trevena Reports Third Quarter 2024 Results and Provides Business Update
High
Report
Trevena Reports Third Quarter 2024 Results and Provides Business Update
11/3
02:07 am
trvn
Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/26
02:10 am
trvn
Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/18
06:44 am
trvn
Opioid addiction market to reach $2.4 billion across 8MM by 2033 [Yahoo! Finance]
Medium
Report
Opioid addiction market to reach $2.4 billion across 8MM by 2033 [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:43 pm
trvn
Form SC 13G/A TREVENA INC Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SC 13G/A TREVENA INC Filed by: ARMISTICE CAPITAL, LLC
11/7
07:16 am
trvn
Form 10-Q TREVENA INC For: Sep 30
High
Report
Form 10-Q TREVENA INC For: Sep 30
11/7
07:05 am
trvn
Form 8-K TREVENA INC For: Nov 05
High
Report
Form 8-K TREVENA INC For: Nov 05
10/10
05:09 pm
trvn
Form 4 TREVENA INC For: Oct 08 Filed by: Demitrack Mark
High
Report
Form 4 TREVENA INC For: Oct 08 Filed by: Demitrack Mark
10/10
05:08 pm
trvn
Form 4 TREVENA INC For: Oct 08 Filed by: Shin Barry
High
Report
Form 4 TREVENA INC For: Oct 08 Filed by: Shin Barry
10/10
05:07 pm
trvn
Form 4 TREVENA INC For: Oct 08 Filed by: Bourdow Carrie L.
High
Report
Form 4 TREVENA INC For: Oct 08 Filed by: Bourdow Carrie L.
10/10
04:40 pm
trvn
Form 8-K TREVENA INC For: Oct 05
High
Report
Form 8-K TREVENA INC For: Oct 05
10/4
04:10 pm
trvn
Form 8-K TREVENA INC For: Oct 04
High
Report
Form 8-K TREVENA INC For: Oct 04
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/4
Form 8-K TREVENA INC For: Mar 03
15.7%
4/13 Form DEF 14A TREVENA INC For: May 13 9.5%
9/6 Form 8-K TREVENA INC For: Sep 03 8.6%
12/12 Trevena Presents Phase 1 Data on TRV250 for Acute Migraine at American College of Neuropsychopharmacology 2019 Annual Meeting 6.3%
12/4 Form 4 TREVENA INC For: Dec 02 Filed by: Bourdow Carrie L. 6.0%
4/23 Trevena Announces Publication of Comprehensive Review of Oliceridine Data 5.5%
5/10 Q1/2019 3/31/2019 EPS -0.060 ZacksConsensus -0.090 ActVsEst 0.030 - Beat 3.3%
6/27 Trevena Appoints Barry Shin as Chief Financial Officer 3.0%
3/13 Form 8-K TREVENA INC For: Mar 12 2.8%
10/11 Trevena Inc (NASDAQ: TRVN) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $1.00 price target on the stock. 2.6%
4/13 Form DEF 14A TREVENA INC For: May 13 9.5%
9/6 Form 8-K TREVENA INC For: Sep 03 8.6%
12/12 Trevena Presents Phase 1 Data on TRV250 for Acute Migraine at American College of Neuropsychopharmacology 2019 Annual Meeting 6.3%
12/4 Form 4 TREVENA INC For: Dec 02 Filed by: Bourdow Carrie L. 6.0%
4/23 Trevena Announces Publication of Comprehensive Review of Oliceridine Data 5.5%
5/10 Q1/2019 3/31/2019 EPS -0.060 ZacksConsensus -0.090 ActVsEst 0.030 - Beat 3.3%
6/27 Trevena Appoints Barry Shin as Chief Financial Officer 3.0%
3/13 Form 8-K TREVENA INC For: Mar 12 2.8%
10/11 Trevena Inc (NASDAQ: TRVN) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $1.00 price target on the stock. 2.6%
TOP News Decliners
11/4
Form 10-Q TREVENA INC For: Sep 30
-21.9%
3/5 Form 8-K TREVENA INC For: Mar 04 -15.4%
6/24 Trevena Announces Publication of APOLLO-2 Results in Pain Practice -11.3%
11/16 Trevena Inc (NASDAQ: TRVN) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -10.5%
7/19 TREVENA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Trevena, Inc. - TRVN -9.5%
3/5 Trevena to Report Fourth Quarter and Full Year 2019 Results on March 12, 2020 -8.3%
2/10 Form 8-K TREVENA INC For: Feb 07 -8.2%
6/20 Trevena Announces Initiation of Healthy Volunteer Study for Oliceridine -7.1%
3/14 Trevena Inc (NASDAQ: TRVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.50 price target on the stock. -6.3%
4/1 Form PRE 14A TREVENA INC For: May 13 -5.9%
3/5 Form 8-K TREVENA INC For: Mar 04 -15.4%
6/24 Trevena Announces Publication of APOLLO-2 Results in Pain Practice -11.3%
11/16 Trevena Inc (NASDAQ: TRVN) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -10.5%
7/19 TREVENA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Trevena, Inc. - TRVN -9.5%
3/5 Trevena to Report Fourth Quarter and Full Year 2019 Results on March 12, 2020 -8.3%
2/10 Form 8-K TREVENA INC For: Feb 07 -8.2%
6/20 Trevena Announces Initiation of Healthy Volunteer Study for Oliceridine -7.1%
3/14 Trevena Inc (NASDAQ: TRVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.50 price target on the stock. -6.3%
4/1 Form PRE 14A TREVENA INC For: May 13 -5.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: